Literature DB >> 23551931

Heme deficiency of soluble guanylate cyclase induces gastroparesis.

S M R Cosyns1, I Dhaese, R Thoonen, E S Buys, A Vral, P Brouckaert, R A Lefebvre.   

Abstract

BACKGROUND: Soluble guanylate cyclase (sGC) is the principal target of nitric oxide (NO) to control gastrointestinal motility. The consequence on nitrergic signaling and gut motility of inducing a heme-free status of sGC, as induced by oxidative stress, was investigated.
METHODS: sGCβ1 (H105F) knock-in (apo-sGC) mice, which express heme-free sGC that has basal activity, but cannot be stimulated by NO, were generated. KEY
RESULTS: Diethylenetriamine NONOate did not increase sGC activity in gastrointestinal tissue of apo-sGC mice. Exogenous NO did not induce relaxation in fundic, jejunal and colonic strips, and pyloric rings of apo-sGC mice. The stomach was enlarged in apo-sGC mice with hypertrophy of the muscularis externa of the fundus and pylorus. In addition, gastric emptying and intestinal transit were delayed and whole-gut transit time was increased in the apo-sGC mice, while distal colonic transit time was maintained. The nitrergic relaxant responses to electrical field stimulation at 1-4 Hz were abolished in fundic and jejunal strips from apo-sGC mice, but in pyloric rings and colonic strips, only the response at 1 Hz was abolished, indicating the contribution of other transmitters than NO. CONCLUSIONS & INFERENCES: The results indicate that the gastrointestinal consequences of switching from a native sGC to a heme-free sGC, which cannot be stimulated by NO, are most pronounced at the level of the stomach establishing a pivotal role of the activation of sGC by NO in normal gastric functioning. In addition, delayed intestinal transit was observed, indicating that nitrergic activation of sGC also plays a role in the lower gastrointestinal tract.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551931      PMCID: PMC4932850          DOI: 10.1111/nmo.12120

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  47 in total

1.  Nitric oxide-sensitive guanylyl cyclase is dispensable for nitrergic signaling and gut motility in mouse intestinal smooth muscle.

Authors:  Dieter Groneberg; Peter König; Doris Koesling; Andreas Friebe
Journal:  Gastroenterology       Date:  2011-01-25       Impact factor: 22.682

2.  Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.

Authors:  Emmanuel S Buys; Patrick Sips; Pieter Vermeersch; Michael J Raher; Elke Rogge; Fumito Ichinose; Mieke Dewerchin; Kenneth D Bloch; Stefan Janssens; Peter Brouckaert
Journal:  Cardiovasc Res       Date:  2008-03-13       Impact factor: 10.787

3.  Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme.

Authors:  A Friebe; G Schultz; D Koesling
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

4.  Nitric oxide and carbon monoxide act as inhibitory neurotransmitters in the longitudinal muscle of C57BL/6J mouse distal colon.

Authors:  Ayako Hidaka; Yasu-Taka Azuma; Hidemitsu Nakajima; Tadayoshi Takeuchi
Journal:  J Pharmacol Sci       Date:  2010-01-30       Impact factor: 3.337

5.  Small intestinal motility in soluble guanylate cyclase alpha1 knockout mice: (Jejunal phenotyping of sGCalpha1 knockout mice).

Authors:  Ingeborg Dhaese; Gwen Vanneste; Patrick Sips; Emmanuel S Buys; Peter Brouckaert; Romain A Lefebvre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-04       Impact factor: 3.000

6.  Evidence for a differential release of nitric oxide and vasoactive intestinal polypeptide by nonadrenergic noncholinergic nerves in the rat gastric fundus.

Authors:  G E Boeckxstaens; P A Pelckmans; J G De Man; H Bult; A G Herman; Y M Van Maercke
Journal:  Arch Int Pharmacodyn Ther       Date:  1992 Jul-Aug

7.  Model of rapid gastrointestinal transit in dogs: effects of muscarinic antagonists and a nitric oxide synthase inhibitor.

Authors:  T Chiba; A E Bharucha; G M Thomforde; L J Kost; S F Phillips
Journal:  Neurogastroenterol Motil       Date:  2002-10       Impact factor: 3.598

8.  Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon.

Authors:  Andrei Sibaev; Birol Yüce; Markus Kemmer; Luc Van Nassauw; Ulli Broedl; Hans D Allescher; Burkhard Göke; Jean-Pierre Timmermans; Martin Storr
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

9.  A novel method for the evaluation of intestinal transit and contractility in mice using fluorescence imaging and spatiotemporal motility mapping.

Authors:  O de Backer; B Blanckaert; L Leybaert; R A Lefebvre
Journal:  Neurogastroenterol Motil       Date:  2008-01-31       Impact factor: 3.598

10.  NANC inhibitory neurotransmission in mouse isolated stomach: involvement of nitric oxide, ATP and vasoactive intestinal polypeptide.

Authors:  Flavia Mulè; Rosa Serio
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

View more
  4 in total

Review 1.  Macrophages in diabetic gastroparesis--the missing link?

Authors:  L Neshatian; S J Gibbons; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2014-08-28       Impact factor: 3.598

Review 2.  CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation.

Authors:  D Babu; R Motterlini; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

3.  Higher susceptibility to heme oxidation and lower protein stability of the rare α1C517Yβ1 sGC variant associated with moyamoya syndrome.

Authors:  Iraida Sharina; Karina Lezgyieva; Yekaterina Krutsenko; Emil Martin
Journal:  Biochem Pharmacol       Date:  2021-02-08       Impact factor: 5.858

4.  Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice.

Authors:  Robrecht Thoonen; Anje Cauwels; Kelly Decaluwe; Sandra Geschka; Robert E Tainsh; Joris Delanghe; Tino Hochepied; Lode De Cauwer; Elke Rogge; Sofie Voet; Patrick Sips; Richard H Karas; Kenneth D Bloch; Marnik Vuylsteke; Johannes-Peter Stasch; Johan Van de Voorde; Emmanuel S Buys; Peter Brouckaert
Journal:  Nat Commun       Date:  2015-10-07       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.